Sangamo Therapeutics (SGMO) Short Interest Ratio & Short Volume $0.50 +0.00 (+0.81%) As of 12:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sangamo Therapeutics Short Interest DataSangamo Therapeutics (SGMO) has a short interest of 24.18 million shares, representing 10.81% of the float (the number of shares available for trading by the public). This marks a -5.80% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 5.93 million shares to cover all short positions.Current Short Interest24,180,000 sharesPrevious Short Interest25,670,000 sharesChange Vs. Previous Month-5.80%Dollar Volume Sold Short$13.09 millionShort Interest Ratio4.4 Days to CoverLast Record DateJune 30, 2025Outstanding Shares233,170,000 sharesShort Percent of Float10.81%Today's Trading Volume1,201,267 sharesAverage Trading Volume5,929,470 sharesToday's Volume Vs. Average20% Short Selling Sangamo Therapeutics? Sign up to receive the latest short interest report for Sangamo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSGMO Short Interest Over TimeSGMO Days to Cover Over TimeSGMO Percentage of Float Shorted Over Time Sangamo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202524,180,000 shares $13.09 million -5.8%10.8%4.4 $0.54 6/15/202525,670,000 shares $12.60 million -17.2%11.5%3.7 $0.49 5/31/202531,010,000 shares $13.99 million -2.8%15.3%4.5 $0.45 5/15/202531,910,000 shares $14.36 million +13.0%15.7%4.6 $0.45 4/30/202528,250,000 shares $21.81 million -4.9%N/A4.3 $0.77 4/15/202529,710,000 shares $21.93 million +16.4%14.6%4.5 $0.74 3/31/202525,520,000 shares $16.84 million -11.7%12.6%3.8 $0.66 3/15/202528,910,000 shares $28.37 million +9.1%14.3%4.6 $0.98 2/28/202526,500,000 shares $27.03 million +4.1%13.1%4.2 $1.02 2/15/202525,460,000 shares $29.79 million +4.6%12.6%4 $1.17 Get the Latest News and Ratings for SGMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sangamo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202524,330,000 shares $29.93 million +8.4%N/A3.3 $1.23 1/15/202522,450,000 shares $24.70 million +4.3%N/A2.2 $1.10 12/31/202421,520,000 shares $21.95 million +9.7%N/A2.2 $1.02 12/15/202419,610,000 shares $40.20 million +31.2%N/A2.4 $2.05 11/30/202414,950,000 shares $33.79 million +11.7%N/A2.1 $2.26 11/15/202413,390,000 shares $27.45 million -29.5%N/A1.9 $2.05 10/31/202418,980,000 shares $32.27 million +4.2%N/A2.6 $1.70 10/15/202418,220,000 shares $17.69 million +0.3%N/A1.5 $0.97 9/30/202418,160,000 shares $15.73 million +3.8%N/A1.3 $0.87 9/15/202417,500,000 shares $14.85 million -2.6%N/A1.2 $0.85 8/31/202417,960,000 shares $15.23 million +11.6%N/A1.3 $0.85 8/15/202416,090,000 shares $14.32 million -16.6%N/A1.2 $0.89 7/31/202419,290,000 shares $15.10 million +51.5%N/A1.5 $0.78 7/15/202412,730,000 shares $5.47 million -17.9%N/A2 $0.43 6/30/202415,510,000 shares $5.56 million +12.4%N/A7.1 $0.36 6/15/202413,800,000 shares $6.90 million +7.8%N/A7.4 $0.50 5/31/202412,800,000 shares $7.22 million -13.1%N/A6.8 $0.56 5/15/202414,730,000 shares $8.54 million +2.6%N/A7.4 $0.58 4/30/202414,360,000 shares $7.39 million +8.4%N/A6.2 $0.51 4/15/202413,250,000 shares $7.36 million +16.1%N/A5.6 $0.56 3/31/202411,410,000 shares $7.65 million +4.9%N/A4.9 $0.67 3/15/202410,880,000 shares $8.49 million +8.2%N/A4.6 $0.78 2/29/202410,060,000 shares $11.67 million +3.4%N/A4.7 $1.16 2/15/20249,730,000 shares $10.22 million -2.5%N/A4.8 $1.05 1/31/20249,980,000 shares $4.56 million +9.0%N/A6 $0.46 1/15/20249,160,000 shares $4.72 million +0.2%N/A5.5 $0.52 12/31/20239,140,000 shares $4.97 million -0.8%N/A4.9 $0.54 12/15/20239,210,000 shares $3.82 million -4.9%N/A4.3 $0.42 11/30/20239,680,000 shares $4.16 million -6.1%N/A4.7 $0.43 11/15/202310,310,000 shares $3.77 million -11.0%N/A4.9 $0.37A new rule goes live in July — and the banks are quietly cashing in (Ad)A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 10/31/202311,590,000 shares $7.30 million +10.4%N/A6.1 $0.63 10/15/202310,500,000 shares $5.88 million +15.3%N/A5.9 $0.56 9/30/20239,110,000 shares $5.46 million -5.2%N/A4.9 $0.60 9/15/20239,610,000 shares $9.60 million -8.1%N/A6.3 $1.00 8/31/202310,460,000 shares $10.14 million -2.5%N/A5.5 $0.97 8/15/202310,730,000 shares $10.84 million -1.5%N/A5.1 $1.01 7/31/202310,890,000 shares $14.32 million -5.2%N/A4.7 $1.32 7/15/202311,490,000 shares $14.82 million -4.0%N/A4.6 $1.29 6/30/202311,970,000 shares $15.56 million -19.2%N/A4.7 $1.30 6/15/202314,820,000 shares $17.19 million +1.9%N/A5.6 $1.16 5/31/202314,540,000 shares $16.28 million -17.4%N/A6.3 $1.12 5/15/202317,610,000 shares $23.60 million -12.9%N/A7.5 $1.34 4/30/202320,220,000 shares $29.72 million +3.8%14.1%9.5 $1.47 4/15/202319,490,000 shares $32.16 million +4.4%13.6%10 $1.65 3/31/202318,670,000 shares $32.86 million +13.8%14.2%10.5 $1.76 3/15/202316,410,000 shares $35.45 million +38.1%12.5%10.1 $2.16 2/28/202311,880,000 shares $36.23 million +2.2%9.0%7.8 $3.05 2/15/202311,620,000 shares $34.86 million -2.5%9.1%8.6 $3.00 1/31/202311,920,000 shares $41.60 million -0.8%9.3%8.8 $3.49 1/15/202312,010,000 shares $43.72 million -2.8%9.4%8.7 $3.64 12/30/202212,360,000 shares $38.81 million +11.0%9.6%9 $3.14 12/15/202211,140,000 shares $36.76 million -1.2%8.7%8.1 $3.30 11/30/202211,270,000 shares $41.25 million -0.7%8.9%8.3 $3.66 11/15/202211,350,000 shares $44.38 million -6.5%9.0%8 $3.91 10/31/202212,140,000 shares $53.29 million +1.3%8.8%8.4 $4.39 10/15/202211,980,000 shares $55.47 million +9.4%9.1%8.3 $4.63 9/30/202210,950,000 shares $53.66 million +17.5%8.3%7.4 $4.90 9/15/20229,320,000 shares $54.06 million +5.6%7.1%6.1 $5.80 8/31/20228,830,000 shares $47.68 million -6.8%6.8%5.5 $5.40 8/15/20229,470,000 shares $60.51 million -4.9%7.3%5.6 $6.39 7/31/20229,960,000 shares $42.73 million -3.5%8.2%5.6 $4.29 7/15/202210,320,000 shares $46.85 million -3.0%8.5%5.9 $4.54 6/30/202210,640,000 shares $44.05 million +1.3%8.8%6.2 $4.14 6/15/202210,500,000 shares $36.23 million +4.9%10.3%6.2 $3.45 5/31/202210,010,000 shares $36.54 million +16.9%8.2%6.7 $3.65 5/15/20228,560,000 shares $34.41 million +6.2%7.0%6.1 $4.02 4/30/20228,060,000 shares $33.45 million +2.8%6.6%6.4 $4.15 4/15/20227,840,000 shares $41.24 million +2.8%6.5%6.4 $5.26 3/31/20227,630,000 shares $44.33 million +8.7%6.3%5.8 $5.81 3/15/20227,020,000 shares $36.78 million -3.7%5.8%5.2 $5.24 2/28/20227,290,000 shares $42.65 million -15.2%6.0%5.2 $5.85 2/15/20228,600,000 shares $51.60 million +2.1%7.1%5.9 $6.00 1/31/20228,420,000 shares $50.77 million -4.0%7.0%6 $6.03 1/15/20228,770,000 shares $56.13 million -1.9%7.3%5.7 $6.40 12/31/20218,940,000 shares $67.05 million -1.3%7.4%6.3 $7.50 12/15/20219,060,000 shares $70.22 million -13.8%7.5%6.9 $7.75 11/30/202110,510,000 shares $87.13 million +1.6%8.7%8.8 $8.29 11/15/202110,350,000 shares $101.64 million +2.2%8.6%9 $9.82 10/29/202110,130,000 shares $82.26 million -0.7%8.4%9.4 $8.12 10/15/202110,200,000 shares $89.25 million -2.5%8.5%12 $8.75A new rule goes live in July — and the banks are quietly cashing in (Ad)A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 9/30/202110,460,000 shares $94.24 million -2.2%8.7%12 $9.01 9/15/202110,690,000 shares $97.92 million -6.3%8.9%11.3 $9.16 8/31/202111,410,000 shares $113.07 million -3.5%9.5%11.9 $9.91 8/13/202111,820,000 shares $118.79 million -1.3%9.8%12.9 $10.05 7/30/202111,980,000 shares $114.77 million -3.0%10.0%12.9 $9.58 7/15/202112,350,000 shares $121.40 million +4.5%10.4%12.7 $9.83 6/30/202111,820,000 shares $141.49 million -13.9%9.9%11.9 $11.97 6/15/202113,730,000 shares $154.74 million -5.2%11.5%13.7 $11.27 5/28/202114,480,000 shares $156.09 million -4.4%12.2%13.3 $10.78 5/14/202115,150,000 shares $157.56 million -0.2%N/A12.3 $10.40 4/30/202115,180,000 shares $180.64 million -5.3%N/A11.2 $11.90 4/15/202116,030,000 shares $186.59 million -3.0%N/A11.1 $11.64 3/31/202116,520,000 shares $192.79 million -0.2%N/A10.8 $11.67 3/15/202116,560,000 shares $191.10 million +6.0%N/A8.8 $11.54 2/26/202115,620,000 shares $174.79 million +0.4%N/A6.6 $11.19 2/12/202115,560,000 shares $215.66 million -0.7%N/A6.7 $13.86 1/29/202115,670,000 shares $222.36 million -6.6%N/A6.6 $14.19 1/15/202116,770,000 shares $271.51 million -2.5%N/A7.1 $16.19 12/31/202017,200,000 shares $289.99 million -1.6%N/A7.4 $16.86 12/15/202017,470,000 shares $228.51 million -13.4%N/A7.9 $13.08 11/30/202020,180,000 shares $204.22 million +4.0%N/A13.3 $10.12 11/15/202019,410,000 shares $222.83 million -4.7%N/A13 $11.48 10/30/202020,370,000 shares $216.13 million -3.4%N/A13.6 $10.61 10/15/202021,090,000 shares $237.47 million -1.2%N/A13.2 $11.26 9/30/202021,350,000 shares $201.76 million +9.1%N/A13.1 $9.45 9/15/202019,570,000 shares $208.81 million +4.4%N/A11.4 $10.67 8/31/202018,750,000 shares $206.81 million -3.1%N/A9.2 $11.03 8/14/202019,340,000 shares $220.28 million +4.4%N/A9.2 $11.39 7/31/202018,520,000 shares $200.57 million -0.2%N/A8.2 $10.83 7/15/202018,550,000 shares $197.19 million -5.7%N/A8.5 $10.63 SGMO Short Interest - Frequently Asked Questions What is Sangamo Therapeutics' current short interest? Short interest is the volume of Sangamo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 24,180,000 shares of SGMO short. 10.81% of Sangamo Therapeutics' shares are currently sold short. Learn More on Sangamo Therapeutics' current short interest. What is a good short interest ratio for Sangamo Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SGMO shares currently have a short interest ratio of 4.0. Learn More on Sangamo Therapeutics's short interest ratio. Which institutional investors are shorting Sangamo Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Sangamo Therapeutics: Jane Street Group LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Sangamo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.81% of Sangamo Therapeutics' floating shares are currently sold short. Is Sangamo Therapeutics' short interest increasing or decreasing? Sangamo Therapeutics saw a decrease in short interest in June. As of June 30th, there was short interest totaling 24,180,000 shares, a decrease of 5.8% from the previous total of 25,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sangamo Therapeutics' short interest compare to its competitors? 10.81% of Sangamo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Sangamo Therapeutics: Emergent Biosolutions Inc. (19.28%), Rigel Pharmaceuticals, Inc. (12.49%), Lexicon Pharmaceuticals, Inc. (10.67%), XOMA Royalty Corporation (373.23%), Vanda Pharmaceuticals Inc. (7.68%), Verastem, Inc. (0.70%), Codexis, Inc. (8.75%), Agenus Inc. (9.73%), Ironwood Pharmaceuticals, Inc. (4.80%), Dominari Holdings Inc. (9.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Sangamo Therapeutics stock? Short selling SGMO is an investing strategy that aims to generate trading profit from Sangamo Therapeutics as its price is falling. SGMO shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sangamo Therapeutics? A short squeeze for Sangamo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SGMO, which in turn drives the price of the stock up even further. How often is Sangamo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGMO, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Emergent Biosolutions Short Interest Rigel Pharmaceuticals Short Interest Lexicon Pharmaceuticals Short Interest XOMA Royalty Short Interest Vanda Pharmaceuticals Short Interest Verastem Short Interest Codexis Short Interest Agenus Short Interest Ironwood Pharmaceuticals Short Interest Dominari Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SGMO) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sangamo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sangamo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGMO Stock Alerts